222 related articles for article (PubMed ID: 20231188)
1. A cost-effectiveness analysis of screening urine dipsticks in well-child care.
Sekhar DL; Wang L; Hollenbeak CS; Widome MD; Paul IM
Pediatrics; 2010 Apr; 125(4):660-3. PubMed ID: 20231188
[TBL] [Abstract][Full Text] [Related]
2. The primary care perspective on routine urine dipstick screening to identify patients with albuminuria.
Samal L; Linder JA
Clin J Am Soc Nephrol; 2013 Jan; 8(1):131-5. PubMed ID: 22917702
[TBL] [Abstract][Full Text] [Related]
3. How effective are screening tests for microalbuminuria in random urine specimens?
Lum G
Ann Clin Lab Sci; 2000 Oct; 30(4):406-11. PubMed ID: 11045765
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
Blake DR; Gaydos CA; Quinn TC
Sex Transm Dis; 2004 Feb; 31(2):85-95. PubMed ID: 14743071
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of urinary dipsticks to screen asymptomatic catheter-associated urinary infections in an intensive care unit.
Tissot E; Woronoff-Lemsi MC; Cornette C; Plesiat P; Jacquet M; Capellier G
Intensive Care Med; 2001 Dec; 27(12):1842-7. PubMed ID: 11797017
[TBL] [Abstract][Full Text] [Related]
7. Screening for proteinuria in US adults: a cost-effectiveness analysis.
Boulware LE; Jaar BG; Tarver-Carr ME; Brancati FL; Powe NR
JAMA; 2003 Dec; 290(23):3101-14. PubMed ID: 14679273
[TBL] [Abstract][Full Text] [Related]
8. Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi.
Floyd K; Skeva J; Nyirenda T; Gausi F; Salaniponi F
Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S29-37. PubMed ID: 12971652
[TBL] [Abstract][Full Text] [Related]
9. Screening dipstick urinalysis: a time to change.
Kaplan RE; Springate JE; Feld LG
Pediatrics; 1997 Dec; 100(6):919-21. PubMed ID: 9374557
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy study of urine dipstick in relation to 24-hour measurement as a screening tool for proteinuria in lupus nephritis.
Siedner MJ; Gelber AC; Rovin BH; McKinley AM; Christopher-Stine L; Astor B; Petri M; Fine DM
J Rheumatol; 2008 Jan; 35(1):84-90. PubMed ID: 18085740
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of strategies that are intended to prevent kernicterus in newborn infants.
Suresh GK; Clark RE
Pediatrics; 2004 Oct; 114(4):917-24. PubMed ID: 15466085
[TBL] [Abstract][Full Text] [Related]
12. Screening for CKD in children: a global controversy.
Hogg RJ
Clin J Am Soc Nephrol; 2009 Feb; 4(2):509-15. PubMed ID: 19118121
[TBL] [Abstract][Full Text] [Related]
13. Evaluating adolescents in juvenile detention facilities for urogenital chlamydial infection: costs and effectiveness of alternative interventions.
Mrus JM; Biro FM; Huang B; Tsevat J
Arch Pediatr Adolesc Med; 2003 Jul; 157(7):696-702. PubMed ID: 12860793
[TBL] [Abstract][Full Text] [Related]
14. Benefit of urinalysis.
Shajari A; Shajari H; Zade MH; Kamali K; Kadivar MR; Nourani F
Indian J Pediatr; 2009 Jun; 76(6):639-41. PubMed ID: 19390814
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of screening for hepatopulmonary syndrome in liver transplant candidates.
Roberts DN; Arguedas MR; Fallon MB
Liver Transpl; 2007 Feb; 13(2):206-14. PubMed ID: 17205561
[TBL] [Abstract][Full Text] [Related]
16. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis.
Plunkett BA; Grobman WA
Am J Obstet Gynecol; 2005 Apr; 192(4):1153-61. PubMed ID: 15846195
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic algorithm for the evaluation of hematuria.
Shen X
J Am Acad Nurse Pract; 2010 Apr; 22(4):186-91. PubMed ID: 20409255
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of universal hepatitis B virus screening in patients beginning chemotherapy for solid tumors.
Day FL; Karnon J; Rischin D
J Clin Oncol; 2011 Aug; 29(24):3270-7. PubMed ID: 21788556
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: factors influencing on international application of evidence-based guidelines.
Hayashino Y; Shimbo T; Tsujii S; Ishii H; Kondo H; Nakamura T; Nagata-Kobayashi S; Fukui T
Int J Cardiol; 2007 May; 118(1):88-96. PubMed ID: 16949690
[TBL] [Abstract][Full Text] [Related]
20. Screening and treatment of asymptomatic bacteriuria of pregnancy to prevent pyelonephritis: a cost-effectiveness and cost-benefit analysis.
Rouse DJ; Andrews WW; Goldenberg RL; Owen J
Obstet Gynecol; 1995 Jul; 86(1):119-23. PubMed ID: 7784004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
